Browse by Medical Category
ALS Multidisciplinary Clinic
The Amyotrophic Lateral Sclerosis (ALS) Multidisciplinary Clinic at Massachusetts General Hospital provides high-quality care along with access to the latest treatments and research opportunities for patients with amyotrophic lateral sclerosis, commonly known as Lou Gehrig’s disease.
ALS Care at Every Stage
Since 1984, Massachusetts General Hospital has been providing the highest quality care to individuals with amyotrophic lateral sclerosis (ALS).
ALS is a disease that affects patients’ health as well as their family, work and social lives. Our ALS Multidisciplinary Clinic provides comprehensive, specialized, sensitive care that addresses all of these needs in one place.
Research suggests that patients who receive treatment at a multidisciplinary ALS clinic live longer and have a higher quality of life. As a patient of our clinic, your care team will include clinicians from a variety of specialties and disciplines who work together to coordinate your care. Having a multidisciplinary care team also allows our patients to receive all their ALS-related care in one place and we can often schedule visits with multiple specialists in one day.
As your needs change over time, we respond accordingly. We take care to offer you and your family guidance in reaching importance decisions along with services, support, and education appropriate to each disease stage.
Multidisciplinary Approach to Diagnosing and Treating ALS
The ALS Clinic and Electromyography (EMG) Lab offer a range of services for the diagnosis and treatment of ALS. We offer information, resources, referrals, and interventions in all areas of need related to the disease.
Our multidisciplinary ALS Clinic specializes in the diagnosis of ALS and offers the most up-to-date clinical therapies and services. Our dedicated staff includes ALS experts in physical therapy, respiratory therapy, nursing and social services. They work closely with our physicians to address and manage the issues that stem from ALS.
ALS Research & Clinical Trials
The Massachusetts General Institute of Neurodegenerative Diseases (MIND) and the MGH Neurological Clinical Research Institute (NCRI) are at the forefront of international ALS research. Our central goals are to improve the diagnosis and treatment of ALS and to discover a cure.
MIND is world-renowned for its basic science research into the genetic and environmental factors that affect ALS and the development of new treatments. The first ALS gene was identified at MIND in 1993 and MIND research is instrumental in the development of new potential treatments for ALS.
Back to Top